Medioro Signature Essence Mist
Olive Oi L
Medifun Inc.
Human Otc Drug
NDC 82363-020Medioro Signature Essence Mist also known as Olive Oi L is a human otc drug labeled by 'Medifun Inc.'. National Drug Code (NDC) number for Medioro Signature Essence Mist is 82363-020. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Medioro Signature Essence Mist drug includes Olive Oil - 1.6 g/160mL . The currest status of Medioro Signature Essence Mist drug is Active.
Drug Information:
| Drug NDC: | 82363-020 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Medioro Signature Essence Mist |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Olive Oi L |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Medifun Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Spray |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | OLIVE OIL - 1.6 g/160mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | VAGINAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Jun, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | MEDIFUN Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| NUI: | N0000191261
M0012553
|
| Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT). |
| UNII: | 6UYK2W1W1E
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
| Pharmacologic Class EPC: | Lipid Emulsion [EPC]
|
| Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`. |
| Pharmacologic Class CS: | Lipids [CS]
|
| Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient]. |
| Pharmacologic Class: | Lipid Emulsion [EPC]
Lipids [CS]
|
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 82363-020-02 | 1 BOTTLE, SPRAY in 1 CARTON (82363-020-02) / 160 mL in 1 BOTTLE, SPRAY (82363-020-01) | 01 Jun, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose antibacterial, odor care, calming the skin
Product Elements:
Medioro signature essence mist olive oi l olive oil olive oil water dipropylene glycol peg-60 hydrogenated castor oil
Indications and Usage:
Uses â antimicrobial and anti-inflammatory effects help. â helps with skin care and skin protection. â it helps to moisturize your skin.
Warnings:
Warnings if the area of use has abnormal symptoms or side effects such as red spots, swelling, or iching, consult a specialist. do not use it in areas with wounds. do not spray around the eyes, mucous membranes,etc. keep out of reach of children keep away from direct sunlight.
Dosage and Administration:
Directions â spray lightly about 10cm away from the area of use. â you can use if from time to time if necessary. â it helps when your skin is dry.
Package Label Principal Display Panel:
Package label.principal display panel image of carton
Further Questions:
Questions â www.medioro.shop / +82) 0507-1390-9493 / medifun35600@gmail.com